BCTX
BriaCell
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
BCTX Profile
Briacell Therapeutics Corp.
A clinical-stage biotechnology company that specializing in targeted immunotherapies for cancer
235 15th Street, Suite 300, West Vancouver, BC, V7T 2X1
--
BriaCell Therapeutics Corp. was founded in British Columbia on July 26, 2006. The company is a clinical-stage biotechnology company that is developing new immunotherapies to transform cancer treatment. Immunotherapies are at the forefront of the fight against cancer because they use the body's own immune system to identify and destroy cancer cells. The company is currently advancing a pivotal Phase 1 Phase 3 study of its Bria-IMT targeted immunotherapy in combination with immune checkpoint inhibitors for advanced metastatic breast cancer.